Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M848Revenue $M31.1Net Margin (%)-280.1Z-Score4.3
Enterprise Value $M695EPS $-10.6Operating Margin %-207.9F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-280.3Higher ROA y-yN
Price/Book11.710-y EBITDA Growth Rate %0Quick Ratio3.5Cash flow > EarningsN
Price/Sales6.75-y EBITDA Growth Rate %0Current Ratio3.5Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-74.3Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)2ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M33.3ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with CHRS

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CHRS is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CHRS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HEALY JAMESDirector 2014-11-12Buy425,926$13.588.44 view
LILLY ELI & CO 2014-11-12Buy164,963$13.588.44 view
Herman Alan C.Chief Scientific Officer 2014-11-06Sell0$088.44 view
Lanfear Dennis MSee Remarks 2014-11-06Sell0$088.44 view
Troendle August J.Director 2014-11-06Sell0$088.44 view
HEALY JAMESDirector 2014-11-06Sell0$088.44 view
Ascena Retail Group, Inc.10% Owner 2012-06-14Sell0$088.44 view
COOPERMAN LEON G10% Owner 2012-03-28Buy432,600$5.6354.29 view
COOPERMAN LEON G10% Owner 2012-02-22Buy291,900$5.21388.29 view
GOLDSTEIN MICHAELDirector 2010-10-15Buy10,000$3.51624.79 view

Press Releases about CHRS :

    Quarterly/Annual Reports about CHRS:

    News about CHRS:

    Articles On GuruFocus.com
    A Look at Pharma Company Dermira's Performance Mar 27 2015 


    More From Other Websites
    COHERUS BIOSCIENCES, INC. Files SEC form 8-K, Other Events Apr 17 2015
    Baxter Amends Financial Provisions of Coherus Collaboration - Analyst Blog Apr 16 2015
    Coherus BioSciences and Baxter Announce Amendment to Etanercept Biosimilar Collaboration Agreement Apr 15 2015
    COHERUS BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Apr 15 2015
    Coherus BioSciences and Baxter Announce Amendment to Etanercept Biosimilar Collaboration Agreement Apr 15 2015
    COHERUS BIOSCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement Apr 14 2015
    Fidelity CEO taps personal fortune for bets on cancer-related IPOs Apr 09 2015
    Weakness Seen in Coherus Biosciences (CHRS): Stock Tumbles 10.8% - Tale of the Tape Apr 02 2015
    Biotechs Raising New Capital in Droves Apr 01 2015
    Coherus Prices Upsized Public Offering of $120.0 Million of Common Stock Mar 31 2015
    Coherus Prices Upsized Public Offering of $120.0 Million of Common Stock Mar 31 2015
    Biosimilars look even more attractive as Novartis makes history Mar 31 2015
    Coherus Announces Proposed Public Offering of Common Stock Mar 30 2015
    Coherus Announces Proposed Public Offering of Common Stock Mar 30 2015
    COHERUS BIOSCIENCES, INC. Financials Mar 27 2015
    Coherus Biosciences (CHRS) Jumps: Stock Moves Up 6.2% - Tale of the Tape Mar 25 2015
    Cramer Remix: I'm taking a cue from Ariana Grande Mar 23 2015
    COHERUS BIOSCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 23 2015
    Coherus BioSciences Reports Fourth Quarter and Year End 2014 Financial and Operating Results Mar 23 2015
    COHERUS BIOSCIENCES, INC. Files SEC form 10-K, Annual Report Mar 23 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK